Gaining business support and securing finances for implementing alternative rapid microbiology methods can be a daunting task. However, at AstraZeneca, they managed to overcome these challenges and change the perception of risk through various strategies.

By demonstrating the value that outweighed the challenges, AstraZeneca successfully embraced and applied a rapid microbial test method using ATP bioluminescence across their synthetic portfolio.

In this informative webinar, attendees will have the opportunity to learn valuable insights on how to navigate the challenges commonly encountered when implementing rapid methods. These include:

• Managing the perception of risk
• Addressing regulatory requirements
• Optimizing financial resources
• Allocating capital
• Ensuring an adequate supply of consumables

By delving into the details of each challenge, attendees will gain practical knowledge and strategies to facilitate the smooth adoption of rapid methods in their own organizations.

In this webinar you’ll learn: How to efficiently and successfully implement a rapid microbiological method within your organization using a proven, industry-tailored framework.

Who should attend:

• Quality Control Microbiology Professionals
• Process Optimization & Automation Engineers
• Production and Manufacturing Planners